We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.
Venetoclax @ BCL2 inhibitor indicated for the treatment of adult patients with CLL or Small Lymphocytic Lymphoma (SLL) with or without 17p deletion, who have received atleast one prior therapy
Venetoclax @ In combination with Azacitadine or Decitabine or low dose Cyterabine for new diagnosed AML > 75 years
Trade Partners
Franchise
Download PDF
+91-9953494942